CERE - Cerevel Therapeutics Holdings, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - CERE (1805387)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
49 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2024-03-04
CEREColes N AnthonyDirS - Sale+OE$41.01-50,00015,638-76%-$2,050,550
D
2024-02-29
CEREColes N AnthonyDirS - Sale+OE$41.16-50,00015,638-76%-$2,057,890
D
2024-02-07
CERERenger JohnChief Scientific OfficerS - Sale+OE$41.54-2,1616,370-25%-$89,777
D
2024-02-07
CEREColes N AnthonyDirS - Sale+OE$41.54-2,50615,638-14%-$104,110
D
2024-01-02
CEREColes N AnthonyDirS - Sale+OE$42.24-50,0002,704-95%-$2,111,815
D
2023-12-26
CERESanchez RamiroChief Medical OfficerS - Sale+OE$42.47-10,00014,673-41%-$424,700
D
2023-12-22
CEREDipietro KennethCHROS - Sale+OE$41.45-8,00024,663-24%-$331,608
D
2023-12-20
CEREBodenrader MarkSee RemarksS - Sale+OE$41.42-7,88917,724-31%-$326,788
D
2023-12-20
CEREDipietro KennethCHROS - Sale+OE$41.42-6,25624,663-20%-$259,144
D
2023-12-20
CEREAkamine ScottGCS - Sale+OE$41.42-7,0727,237-49%-$292,945
D
2023-12-20
CERESanchez RamiroChief Medical OfficerS - Sale+OE$41.42-10,15214,673-41%-$420,528
D
2023-12-20
CEREAltschuller SusanCFOS - Sale+OE$41.42-13,80816,913-45%-$571,972
D
2023-12-20
CERETregoning KathleenSee RemarksS - Sale+OE$41.42-6,2887,516-46%-$260,469
D
2023-12-15
CERESanchez RamiroChief Medical OfficerS - Sale+OE$41.39-7,5000-100%-$310,393
D
2023-12-07
CERESanchez RamiroChief Medical OfficerS - Sale+OE$41.37-10,0000-100%-$413,700
DM
2023-12-05
CEREAkamine ScottGCS - Sale+OE$38.64-17,500513-97%-$676,200
D
2023-11-14
CEREColes N AnthonyDirS - Sale+OE$25.13-22,8242,704-89%-$573,455
DM
2023-11-07
CEREColes N AnthonyDirS - Sale+OE$25.02-27,1762,704-91%-$680,071
DM
2023-11-02
CEREColes N AnthonyDirS - Sale+OE$25.34-100,0002,704-97%-$2,533,697
D
2023-11-01
CEREPatrick Deval LDirS - Sale+OE$25.00-30,1303,282-90%-$753,250
2023-10-16
CEREGordon Christopher RDir, 10%P - Purchase$22.81+5,480,05265,683,063+9%+$124,999,986
2023-10-16
CEREKoppel AdamDir, 10%P - Purchase$22.81+5,480,05265,683,063+9%+$124,999,986
2023-10-16
CEREBain Capital Investors LLC10%P - Purchase$22.81+5,480,05265,679,781+9%+$124,999,986
2023-10-16
CEREPerceptive Advisors LLCDirP - Purchase$22.81+876,80810,965,193+9%+$19,999,990
D
2023-09-07
CEREColes N AnthonyDirS - Sale+OE$24.07-50,0002,704-95%-$1,203,415
2023-08-03
CERERenaud Ronald C JrPres, CEOP - Purchase$23.96+83,85783,857New+$2,008,811
2023-08-04
CEREBurgess Paul D.See RemarksP - Purchase$22.93+21,88021,880New+$501,794
D
2023-07-11
CEREColes N AnthonyDirS - Sale+OE$30.03-50,0002,704-95%-$1,501,340
2023-06-15
CEREDekkers Marijn EDirS - Sale$34.43-200,000434,148-32%-$6,886,000
D
2023-06-01
CEREColes N AnthonyCEO, ChairpersonS - Sale+OE$32.60-50,0002,704-95%-$1,630,070
D
2023-06-02
CEREBodenrader MarkSee RemarksS - Sale+OE$32.95-1,8955,522-26%-$62,440
D
2023-05-04
CEREColes N AnthonyCEO, ChairpersonS - Sale+OE$31.47-50,0002,704-95%-$1,573,434
D
2023-04-11
CEREColes N AnthonyCEO, ChairpersonS - Sale+OE$25.06-50,0002,704-95%-$1,253,130
DM
2023-03-02
CEREColes N AnthonyCEO, ChairpersonS - Sale+OE$27.12-50,0002,704-95%-$1,355,947
D
2023-02-07
CEREColes N AnthonyCEO, ChairpersonS - Sale+OE$33.13-50,0002,704-95%-$1,656,401
D
2023-01-05
CEREColes N AnthonyCEO, ChairpersonS - Sale+OE$29.94-50,0002,704-95%-$1,496,871
D
2022-12-09
CEREColes N AnthonyCEO, ChairpersonS - Sale+OE$26.67-50,0002,704-95%-$1,333,300
D
2022-11-01
CERERenger JohnChief Scientific OfficerS - Sale+OE$30.00-25,0002,704-90%-$750,005
D
2022-10-04
CERERenger JohnChief Scientific OfficerS - Sale+OE$30.00-25,0002,704-90%-$750,000
D
2022-09-12
CEREPatrick Deval LDirS - Sale+OE$30.78-47,7050-100%-$1,468,422
D
2022-09-08
CERECeesay AbrahamPresS - Sale+OE$32.50-19,2100-100%-$624,325
D
2022-08-22
CERECeesay AbrahamPresS - Sale+OE$32.50-9,6050-100%-$312,163
D
2022-08-16
CEREPerceptive Advisors LLCDirP - Purchase$35.00+1,425,0006,511,727+28%+$49,875,000
D
2022-08-15
CERECeesay AbrahamPresS - Sale+OE$34.12-9,6060-100%-$327,757
D
2022-08-10
CERERenger JohnChief Scientific OfficerS - Sale+OE$40.50-55,0002,704-95%-$2,227,624
D
2022-07-20
CERERenger JohnChief Scientific OfficerS - Sale+OE$30.00-25,0002,704-90%-$750,000
DM
2022-07-05
CERERenger JohnChief Scientific OfficerS - Sale+OE$30.11-26,1052,704-91%-$785,913
D
2022-04-13
CERERenger JohnChief Scientific OfficerS - Sale+OE$34.65-45,0001,980-96%-$1,559,093
D
2022-03-29
CERERenger JohnChief Scientific OfficerS - Sale+OE$35.00-10,0001,980-83%-$350,000

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top